chrX-153787885-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_004135.4(IDH3G):​c.478G>T​(p.Asp160Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 25)

Consequence

IDH3G
NM_004135.4 missense

Scores

2
11
4

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.203
Variant links:
Genes affected
IDH3G (HGNC:5386): (isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma) Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. NAD(+)-dependent isocitrate dehydrogenases catalyze the allosterically regulated rate-limiting step of the tricarboxylic acid cycle. Each isozyme is a heterotetramer that is composed of two alpha subunits, one beta subunit, and one gamma subunit. The protein encoded by this gene is the gamma subunit of one isozyme of NAD(+)-dependent isocitrate dehydrogenase. This gene is a candidate gene for periventricular heterotopia. Several alternatively spliced transcript variants of this gene have been described, but only some of their full length natures have been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
IDH3GNM_004135.4 linkuse as main transcriptc.478G>T p.Asp160Tyr missense_variant 7/13 ENST00000217901.10 NP_004126.1 P51553-1
IDH3GNM_174869.3 linkuse as main transcriptc.478G>T p.Asp160Tyr missense_variant 7/12 NP_777358.1 P51553-2O15384

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
IDH3GENST00000217901.10 linkuse as main transcriptc.478G>T p.Asp160Tyr missense_variant 7/131 NM_004135.4 ENSP00000217901.5 P51553-1

Frequencies

GnomAD3 genomes
Cov.:
25
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
25

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 05, 2024The c.478G>T (p.D160Y) alteration is located in exon 7 (coding exon 7) of the IDH3G gene. This alteration results from a G to T substitution at nucleotide position 478, causing the aspartic acid (D) at amino acid position 160 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Uncertain
0.038
T
BayesDel_noAF
Benign
-0.18
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.89
.;D;.;D;D;D;D
FATHMM_MKL
Benign
0.38
N
LIST_S2
Uncertain
0.93
D;D;D;.;D;D;D
M_CAP
Uncertain
0.18
D
MetaRNN
Uncertain
0.46
T;T;T;T;T;T;T
MetaSVM
Uncertain
-0.13
T
MutationAssessor
Uncertain
2.7
M;M;.;.;.;.;.
PrimateAI
Uncertain
0.58
T
PROVEAN
Pathogenic
-5.0
D;D;D;D;.;D;D
REVEL
Uncertain
0.35
Sift
Uncertain
0.0020
D;D;D;D;.;D;D
Sift4G
Uncertain
0.0050
D;D;D;D;D;D;D
Polyphen
0.99
.;D;.;.;.;.;.
Vest4
0.56
MutPred
0.53
Loss of catalytic residue at D160 (P = 0.0704);Loss of catalytic residue at D160 (P = 0.0704);Loss of catalytic residue at D160 (P = 0.0704);.;.;.;.;
MVP
0.68
MPC
2.2
ClinPred
0.99
D
GERP RS
5.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.85
gMVP
0.99

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chrX-153053340; API